ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $74,000 | -6.3% | 2,233 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $79,000 | -23.3% | 2,233 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $103,000 | -30.4% | 2,233 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $148,000 | +6.5% | 2,233 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $139,000 | -24.9% | 2,233 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $185,000 | +25.0% | 2,233 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $148,000 | -13.5% | 2,233 | 0.0% | 0.01% | -41.7% |
| Q4 2020 | $171,000 | +78.1% | 2,233 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $96,000 | 0.0% | 2,233 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $96,000 | -99.9% | 2,233 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $64,243,000 | -64.2% | 2,233 | -21.2% | 0.01% | -60.9% |
| Q4 2019 | $179,697,000 | +54.3% | 2,833 | -31.5% | 0.02% | +64.3% |
| Q3 2019 | $116,467,000 | – | 4,133 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |